RecruitingPhase 3NCT07437404

Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

An Open Label, Uncontrolled Study to Evaluate the the Safety and Efficacy of SCT800 for Prophylaxis Treatment in Severe Previously Untreated Hemophilia Patients.

Sponsor

Sinocelltech Ltd.

Enrollment

36 participants

Start Date

Apr 26, 2024

Study Type

INTERVENTIONAL

Conditions

Haemophilia A

Summary

This is an Open Label, Uncontrolled Study to Evaluate the the Safety and Efficacy of SCT800 for Prophylaxis Treatment in Severe Previously Untreated Hemophilia Patients.

Eligibility

Sex: MALEMax Age: 6 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called SCT800 prophylaxis and treatment for bleeding events for people with haemophilia a. The study is currently recruiting participants at 1 location. People eligible for this study include men up to age 6 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSCT800 prophylaxis and treatment for bleeding events

For prophylaxis, 15-50 IU/kg SCT800 is intravenously. For control of bleeding events(BE), 10-20 IU/kg for mild BE, 15 -30IU/kg for moderate BE, 30-50IU/kg for severe BE.

Locations(1)

Beijing children's hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07437404

Related Trials

A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A

NCT05685238152 locations

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

NCT0369597859 locations

A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

NCT0722056433 locations

A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI

NCT022078941 location

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

NCT065749847 locations